Cargando…
Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression
Background: Curcumin has been shown to exert pleiotropic biological effects, including anti-tumorigenic activity. We previously showed that curcumin controls reactive oxygen species (ROS) levels through the ROS metabolic enzymes, to prevent tumor cell growth. In this study, we synthesized 39 novel c...
Autores principales: | Nakamae, Ikuko, Morimoto, Tsumoru, Shima, Hiroki, Shionyu, Masafumi, Fujiki, Hisayo, Yoneda-Kato, Noriko, Yokoyama, Takashi, Kanaya, Shigehiko, Kakiuchi, Kiyomi, Shirai, Tsuyoshi, Meiyanto, Edy, Kato, Jun-ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891586/ https://www.ncbi.nlm.nih.gov/pubmed/31717651 http://dx.doi.org/10.3390/molecules24224067 |
Ejemplares similares
-
Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence
por: Lestari, Beni, et al.
Publicado: (2019) -
Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth
por: Larasati, Yonika Arum, et al.
Publicado: (2018) -
Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation
por: Meiyanto, Edy, et al.
Publicado: (2019) -
Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins
por: Hijikata, Atsushi, et al.
Publicado: (2021) -
Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models
por: Kamitani, Naoki, et al.
Publicado: (2022)